MilliporeSigma
  • Home
  • Search Results
  • Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators.

Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators.

PloS one (2014-10-11)
Vance Holt, Arnold I Caplan, Stephen E Haynesworth
ABSTRACT

Increased marrow medullary adipogenesis and an associated decrease in bone mineral density, usually observed in elderly individuals, is a common characteristic in senile osteoporosis. In this study we investigated whether cells of the medullary adipocyte lineage have the potential to directly support the formation of osteoclasts, whose activity in bone leads to bone degradation. An in vitro mesenchymal stem cell (MSC)-derived medullary adipocyte lineage culture model was used to study the expression of the important osteoclast mediators RANKL, M-CSF, SDF-1, and OPG. We further assessed whether adipocytes at a specific developmental stage were capable of supporting osteoclast-like cell formation in culture. In vitro MSC-derived medullary adipocytes showed an mRNA and protein expression profile of M-CSF, RANKL, and OPG that was dependent on its developmental/metabolic stage. Furthermore, RANKL expression was observed in MSC-derived adipocytes that were at a distinct lineage stage and these cells were also capable of supporting osteoclast-like cell formation in co-cultures with peripheral blood mononuclear cells. These results suggest a connection between medullary adipocytes and osteoclast formation in vivo and may have major significance in regards to the mechanisms of decreased bone density in senile osteoporosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
ANTI-RUNX2 antibody produced in mouse, clone 4E5, ascites fluid
Sigma-Aldrich
ANTI-RUNX2 antibody produced in mouse, clone 4D7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RUNX2 antibody produced in mouse, clone 4B4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-RUNX2 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0235, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
ANTI-RUNX2 antibody produced in mouse, clone 3F5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
ANTI-RUNX2 antibody produced in mouse, clone 1D2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-PPARA antibody produced in mouse, clone 1A8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-RUNX2 antibody produced in mouse, clone 4D5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-Peroxisome Proliferator Activated Receptor α antibody produced in mouse, ~1 mg/mL, clone 3B6/PPAR, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe, ≥97% (HPLC)
Sigma-Aldrich
Monoclonal Anti-RUNX2 antibody produced in mouse, clone 1D8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-RUNX2 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0232, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
RANK Ligand/TRANCE human, >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
Sigma-Aldrich
sRANKL human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
Anti-PPARA antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Supelco
Hematoxylin
Sigma-Aldrich
Hematoxylin, certified by the Biological Stain Commission